Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Moriarty

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
The American Journal of Cardiology|October 24, 2007
Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterolIsaac O Opole, John M Belmont, Amit Kumar, et al.
Journal of Clinical Lipidology|March 6, 2012
The use of lipopheresis in the practice of clinical lipidologyW Virgil Brown, Robert Brook, Linda C Hemphill, et al.
Journal of Clinical Lipidology|August 8, 2025
Pelacarsen: Mechanism of action and Lp(a)-lowering effectHarpreet S Bhatia, Archna Bajaj, Sascha N Goonewardena, et al.
Atherosclerosis|May 28, 2011
A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgiasJames M Backes, Brian J Barnes, Janelle F Ruisinger, et al.
Lipids|July 9, 2011
Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapyJames M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The Annals of Pharmacotherapy|November 19, 2009
Does simvastatin cause more myotoxicity compared with other statins?James M Backes, Patricia A Howard, Janelle F Ruisinger, et al.
North American Journal of Medical Sciences|August 11, 2015
Statin Intolerance and Vitamin D Supplementation: Sunny, but a Few Clouds Remain…James M Backes, Janelle F Ruisinger, Brian J Barnes, et al.
Pharmacotherapy|February 24, 2007
Fibrates: what have we learned in the past 40 years?James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The American Journal of Cardiology|January 27, 2009
Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intoleranceJanelle F Ruisinger, James M Backes, Cheryl A Gibson, et al.
The American Journal of Cardiology|July 31, 2007
Effects of once weekly rosuvastatin among patients with a prior statin intoleranceJames M Backes, Patrick M Moriarty, Janelle F Ruisinger, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
The American Journal of Cardiology|October 24, 2007
Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterolIsaac O Opole, John M Belmont, Amit Kumar, et al.
Journal of Clinical Lipidology|March 6, 2012
The use of lipopheresis in the practice of clinical lipidologyW Virgil Brown, Robert Brook, Linda C Hemphill, et al.
Journal of Clinical Lipidology|August 8, 2025
Pelacarsen: Mechanism of action and Lp(a)-lowering effectHarpreet S Bhatia, Archna Bajaj, Sascha N Goonewardena, et al.
Atherosclerosis|May 28, 2011
A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgiasJames M Backes, Brian J Barnes, Janelle F Ruisinger, et al.
Lipids|July 9, 2011
Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapyJames M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The Annals of Pharmacotherapy|November 19, 2009
Does simvastatin cause more myotoxicity compared with other statins?James M Backes, Patricia A Howard, Janelle F Ruisinger, et al.
North American Journal of Medical Sciences|August 11, 2015
Statin Intolerance and Vitamin D Supplementation: Sunny, but a Few Clouds Remain…James M Backes, Janelle F Ruisinger, Brian J Barnes, et al.
Pharmacotherapy|February 24, 2007
Fibrates: what have we learned in the past 40 years?James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The American Journal of Cardiology|January 27, 2009
Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intoleranceJanelle F Ruisinger, James M Backes, Cheryl A Gibson, et al.
The American Journal of Cardiology|July 31, 2007
Effects of once weekly rosuvastatin among patients with a prior statin intoleranceJames M Backes, Patrick M Moriarty, Janelle F Ruisinger, et al.
Pageof 12